First Time Loading...

Novozymes A/S
CSE:NZYM B

Watchlist Manager
Novozymes A/S Logo
Novozymes A/S
CSE:NZYM B
Watchlist
Price: 403 DKK -3.93% Market Closed
Updated: May 1, 2024

Intrinsic Value

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. [ Read More ]

The intrinsic value of one NZYM B stock under the Base Case scenario is 124.83 DKK. Compared to the current market price of 403 DKK, Novozymes A/S is Overvalued by 69%.

Key Points:
NZYM B Intrinsic Value
Base Case
124.83 DKK
Overvaluation 69%
Intrinsic Value
Price
Worst Case
Base Case
Best Case

Valuation Backtest
Novozymes A/S

Backtest Intrinsic Value
Dive into the past to invest in the future

Run backtest to discover the historical profit from buying and selling NZYM B stocks based on their intrinsic value.

Analyze the historical link between intrinsic value and market price to make more informed investment decisions.

Run Backtest
Settings
Valuation Methods
Buy/Sell Thresholds
Buy When:
%
Sell When:
%
B
S
Run Backtest
How does it work?

Fundamental Analysis

Beta
Ask me anything about
Novozymes A/S

Provide an overview of the primary business activities
of Novozymes A/S.

What unique competitive advantages
does Novozymes A/S hold over its rivals?

What risks and challenges
does Novozymes A/S face in the near future?

Summarize the latest earnings call
of Novozymes A/S.

Is it considered overvalued or undervalued
based on the latest financial data?

Show all valuation multiples
for Novozymes A/S.

Provide P/S
for Novozymes A/S.

Provide P/E
for Novozymes A/S.

Provide P/OCF
for Novozymes A/S.

Provide P/FCFE
for Novozymes A/S.

Provide P/B
for Novozymes A/S.

Provide EV/S
for Novozymes A/S.

Provide EV/GP
for Novozymes A/S.

Provide EV/EBITDA
for Novozymes A/S.

Provide EV/EBIT
for Novozymes A/S.

Provide EV/OCF
for Novozymes A/S.

Provide EV/FCFF
for Novozymes A/S.

Provide EV/IC
for Novozymes A/S.

Show me price targets
for Novozymes A/S made by professional analysts.

What are the Revenue projections
for Novozymes A/S?

How accurate were the past Revenue estimates
for Novozymes A/S?

What are the Net Income projections
for Novozymes A/S?

How accurate were the past Net Income estimates
for Novozymes A/S?

What are the EPS projections
for Novozymes A/S?

How accurate were the past EPS estimates
for Novozymes A/S?

What are the EBIT projections
for Novozymes A/S?

How accurate were the past EBIT estimates
for Novozymes A/S?

Compare the revenue forecasts
for Novozymes A/S with those of its competitors based on recent analyst estimates.

Compare the intrinsic valuations
of Novozymes A/S and its key competitors using the latest financial data.

Compare historical revenue growth rates
of Novozymes A/S against its competitors.

Analyze the profit margins
(gross, operating, and net) of Novozymes A/S compared to its peers.

Compare the P/E ratios
of Novozymes A/S against its peers.

Discuss the investment returns and shareholder value creation
comparing Novozymes A/S with its peers.

Analyze the financial leverage
of Novozymes A/S compared to its main competitors.

Show all profitability ratios
for Novozymes A/S.

Provide ROE
for Novozymes A/S.

Provide ROA
for Novozymes A/S.

Provide ROIC
for Novozymes A/S.

Provide ROCE
for Novozymes A/S.

Provide Gross Margin
for Novozymes A/S.

Provide Operating Margin
for Novozymes A/S.

Provide Net Margin
for Novozymes A/S.

Provide FCF Margin
for Novozymes A/S.

Show all solvency ratios
for Novozymes A/S.

Provide D/E Ratio
for Novozymes A/S.

Provide D/A Ratio
for Novozymes A/S.

Provide Interest Coverage Ratio
for Novozymes A/S.

Provide Altman Z-Score Ratio
for Novozymes A/S.

Provide Quick Ratio
for Novozymes A/S.

Provide Current Ratio
for Novozymes A/S.

Provide Cash Ratio
for Novozymes A/S.

What is the historical Revenue growth
over the last 5 years for Novozymes A/S?

What is the historical Net Income growth
over the last 5 years for Novozymes A/S?

What is the current Free Cash Flow
of Novozymes A/S?

Discuss the annual earnings per share (EPS)
trend over the past five years for Novozymes A/S.

Financials

Balance Sheet Decomposition
Novozymes A/S

Current Assets 9.5B
Cash & Short-Term Investments 1.2B
Receivables 4.3B
Other Current Assets 4B
Non-Current Assets 18.9B
Long-Term Investments 267m
PP&E 12.3B
Intangibles 4.5B
Other Non-Current Assets 1.8B
Current Liabilities 7.3B
Accounts Payable 1.6B
Other Current Liabilities 5.6B
Non-Current Liabilities 7.2B
Long-Term Debt 4.6B
Other Non-Current Liabilities 2.6B
Efficiency

Earnings Waterfall
Novozymes A/S

Revenue
17.9B DKK
Cost of Revenue
-8.2B DKK
Gross Profit
9.7B DKK
Operating Expenses
-5.3B DKK
Operating Income
4.5B DKK
Other Expenses
-1.4B DKK
Net Income
3B DKK

Free Cash Flow Analysis
Novozymes A/S

Last Value
3-Years Average
FCF Margin
Conversion Rate
History
Components
Chart
Table
Fundamental Scores

NZYM B Profitability Score
Profitability Due Diligence

Novozymes A/S's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

Positive Gross Profit
Exceptional 3-Year Average ROE
Positive Free Cash Flow
Positive Operating Income
63/100
Profitability
Score

Novozymes A/S's profitability score is 63/100. The higher the profitability score, the more profitable the company is.

NZYM B Solvency Score
Solvency Due Diligence

Novozymes A/S's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

High Interest Coverage
High Altman Z-Score
Low D/E
Long-Term Solvency
76/100
Solvency
Score

Novozymes A/S's solvency score is 76/100. The higher the solvency score, the more solvent the company is.

Wall St
Price Targets

NZYM B Price Targets Summary
Novozymes A/S

Wall Street analysts forecast NZYM B stock price to rise over the next 12 months.

According to Wall Street analysts, the average 1-year price target for NZYM B is 405.07 DKK .

Lowest
Price Target
Not Available
Average
Price Target
405.07 DKK
1% Upside
Highest
Price Target
Not Available
View Analyst Estimates
View Analyst Estimates

Competitive Landscape

Shareholder Return

NZYM B Price
Novozymes A/S

1M 1M
-
6M 6M
+27%
1Y 1Y
+14%
3Y 3Y
-6%
5Y 5Y
+37%
10Y 10Y
+74%
Annual Price Range
403
52w Low
276.6
52w High
419.5
Price Metrics
Average Annual Return 9.12%
Standard Deviation of Annual Returns 35.93%
Max Drawdown -47%
Shares Statistics
Market Capitalization 165.6B DKK
Shares Outstanding 410 872 446
Percentage of Shares Shorted
N/A

NZYM B Return Decomposition
Main factors of price return

What is price return decomposition?

NZYM B News

Other Videos

Company Profile

Novozymes A/S Logo
Novozymes A/S

Country

Denmark

Industry

Chemicals

Market Cap

165.6B DKK

Dividend Yield

0%

Description

Novozymes A/S engages in the research and development of biotechnology solutions, which produces industrial enzymes and microorganisms. The firm operates in four geographical regions: Europe, Middle East & Africa (including Denmark), North America, Asia Pacific and Latin America. The company develops and distributes solutions within the market areas agriculture, bioenergy, food & beverages, household care, leather, pharmaceuticals, forest products, textile and wastewater solutions. Novozymes operates through a range of partnerships with companies, such as Adisseo, Beta Renewables, DONG Energy and Monsanto, and is a parent company of Novozymes Belgium BVBA, Novozymes BioAg Limited, Novozymes Canada Limited, Albumedix A/S and Organobalance GmbH, among others.

Contact

Bagsvaerd
Krogshoejvej 36
https://www.novozymes.com/

IPO

1905-05-27

Employees

6 184

Officers

See Also

Discover More
What is the Intrinsic Value of one NZYM B stock?

The intrinsic value of one NZYM B stock under the Base Case scenario is 124.83 DKK.

Is NZYM B stock undervalued or overvalued?

Compared to the current market price of 403 DKK, Novozymes A/S is Overvalued by 69%.